Sep 2026· Nutrition and Health· pp.
2601060261487771
· 0 citations· 40 references
Medicine
TL;DR
Wheat bran supplementation attenuates HFD-induced metabolic disturbances and improves body weight regulation, lipid profiles and overall health and demonstrates its potential role as a functional dietary intervention in the prevention and management of obesity-related metabolic disorders.
Abstract
BackgroundA high-fat diet (HFD) is associated with excessive energy intake that leads to weight gain, adiposity, dyslipidaemia, chronic low-grade inflammation and metabolic dysregulation. Wheat bran (WB), a fibre-rich by-product of wheat milling, improves satiety, regulates lipid absorption, modulates the gut microbiota and enhances antioxidant and anti-inflammatory activities. Therefore, it has protective effects against obesity and related metabolic disorders.Aim: This study aimed to investigate the protective effects of WB incorporated into an HFD and evaluate its role in the modulation of body weight, biochemical parameters and overall metabolic outcomes.MethodsMale Wistar rats were randomly assigned to three dietary groups and fed a standard chow diet (CD), HFD or HFD supplemented with WB (HFWB).ResultsRats fed the HFWB exhibited 40-60% less weight gain than those fed CD and HFD. Biochemical parameters, including the lipid profile and markers of metabolic health, significantly improved in the HFWB group compared to those in other groups. Moreover, abdominal fat accumulation was markedly reduced, and hepatic steatosis was ameliorated in HFWB-fed rats. Metabolic profiling showed that the HFD-induced oxidative stress and disrupted bile acid, folate and lipid metabolism. Contrastingly, WB supplementation partially restored the redox balance and reprogrammed amino acid and energy pathways.ConclusionWB supplementation attenuates HFD-induced metabolic disturbances and improves body weight regulation, lipid profiles and overall health. These results demonstrate its potential role as a functional dietary intervention in the prevention and management of obesity-related metabolic disorders.
Background: Obesity is a major metabolic disorder associated with an increased risk of diabetes, cardiovascular disease, and liver damage. Medicinal plants with antioxidant and metabolism-regulating properties may offer a complementary approach to managing obesity-related complications. Objectives: This study aimed to...
Background/Objectives: Obesity is linked to hepatic metabolic dysfunction and inflammation. Combined aerobic and resistance exercise is associated with improved body composition, but its effects on liver metabolomics remain unclear. This study examined an 8-week combined exercise intervention in high-fat diet (HFD)-ind...
High-fat diet (HFD)-induced obesity is associated with metabolic dysfunction, oxidative stress, chronic inflammation, and progressive injury to metabolically active organs including the liver and kidneys. Cucumeropsis mannii is an underutilised oilseed rich in bioactive phytochemicals with reported antioxidant and hypo...
Damilola Mogbojuri, A. Onaolapo, O. Onaolapo· Acta Bioscientia: Journal of...· 0 citations
High-fat diet (HFD)-induced obesity is associated with metabolic dysfunction, oxidative stress, chronic inflammation, and progressive injury to metabolically active organs including the liver and kidneys. Cucumeropsis mannii is an underutilised oilseed rich in bioactive phytochemicals with reported antioxidant and hypo...
N. Opadokun· Acta Bioscientia: Journal of...· 0 citations
Background/Objectives: High-protein (HP) diets may influence body composition, lipid metabolism, oxidative stress, and mitochondrial function, but their interaction with probiotics remains unclear. This study evaluated the effects of HP feeding, alone or combined with Lactobacillus acidophilus and Bifidobacterium lacti...
Luiza Ferracini Cunha, Isabella Pompeu Mattos Almeida, Andrew Oliveira Silva et al.· Nutrients· 0 citations
Findings indicated that C. mas L. ameliorates hepatic insulin resistance in HFD-induced T2D mice by regulating the transcriptional level of glucolipid metabolism-related genes, suggesting that the protective effects of C. mas could serve as a novel strategy for the treatment of T2D.